In Brief
- More than 16,000 doses of Ervebo vaccine arrived in Ebola-hit DRC.
- Ervebo has been widely used, including during 2018-2020 outbreak in DRC.
- Vaccine delivery aids ongoing efforts to control the Ebola outbreak.
- DRC's Minister of Health highlighted vaccine’s crucial role in outbreak response.
More than 16,000 doses of the Ervebo vaccine have reached the Democratic Republic of Congo (DRC) to combat the ongoing Ebola outbreak. The delivery is part of efforts to contain the virus and protect at-risk populations.
Samuel Roger Kamba, DRC's Minister of Health, stated that the Ervebo vaccine has been used several times previously, notably on a large scale during the 2018-2020 Ebola outbreak. The vaccine's established efficacy and prior extensive deployment make it a key tool in the current response.
The arrival of these doses is expected to strengthen vaccination campaigns targeted at healthcare workers and individuals exposed to Ebola, thereby reducing transmission and saving lives. Health authorities continue to monitor the situation closely and coordinate vaccination efforts across affected regions.
